Literature DB >> 19808310

Absolute and attributable risks of heart failure incidence in relation to optimal risk factors.

Aaron R Folsom1, Kazumasa Yamagishi, Atsushi Hozawa, Lloyd E Chambless.   

Abstract

BACKGROUND: Epidemiological studies have shown that a large proportion of coronary heart disease and stroke events are explained by borderline or elevated risk factors and that adults with optimal risk factors greatly avoid these events. The degree to which this applies to heart failure incidence is not well documented. METHODS AND
RESULTS: We categorized baseline (1987-1989) risk factors in the Atherosclerosis Risk in Communities Study cohort (n=13,460, aged 45 to 64 years) into optimal, borderline, and elevated groups based on national guidelines, using a 4-factor score (blood pressure, plasma cholesterol, diabetes, and smoking) and a 5-factor score (which included body mass). Incidence of hospitalized heart failure (n=1344) was identified over a 16-year period. Only 4.9% of the cohort at baseline had all optimal risk factors based on the 4-factor score and 2.6% using the 5-factor score. Compared with participants with any elevated risk factor using the 4-factor score, the age-, sex-, and race-adjusted relative hazard for heart failure events was 0.18 (95% CI, 0.10 to 0.32) for those with all optimal risk factors and 0.35 (95% CI, 0.30 to 0.41) for those with only borderline risk factors. A population-attributable fraction estimate suggested that having at least 1 of the 4 risk factors, elevated or borderline, accounted for 77.1% of heart failure events. For the 5-factor score, that percentage was 88.8%.
CONCLUSIONS: Middle-aged adults with optimal (low) risk factors have low incidence rates of heart failure, which supports redoubled efforts to prevent risk factor development in the first place.

Entities:  

Mesh:

Year:  2009        PMID: 19808310      PMCID: PMC2637354          DOI: 10.1161/CIRCHEARTFAILURE.108.794933

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  29 in total

1.  Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors.

Authors:  Sameer Sharma; Ann M Malarcher; Wayne H Giles; Gary Myers
Journal:  Ethn Dis       Date:  2004       Impact factor: 1.847

2.  Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

Authors:  J Stamler; R Stamler; J D Neaton; D Wentworth; M L Daviglus; D Garside; A R Dyer; K Liu; P Greenland
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Congestive heart failure incidence and prognosis: case identification using central adjudication versus hospital discharge diagnoses.

Authors:  Gina D Schellenbaum; Susan R Heckbert; Nicholas L Smith; Thomas D Rea; Thomas Lumley; Dalane W Kitzman; Veronique L Roger; Herman A Taylor; Bruce M Psaty
Journal:  Ann Epidemiol       Date:  2005-06-16       Impact factor: 3.797

4.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

5.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

6.  Relative importance of borderline and elevated levels of coronary heart disease risk factors.

Authors:  Ramachandran S Vasan; Lisa M Sullivan; Peter W F Wilson; Christopher T Sempos; Johan Sundström; William B Kannel; Daniel Levy; Ralph B D'Agostino
Journal:  Ann Intern Med       Date:  2005-03-15       Impact factor: 25.391

7.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

Authors:  W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

8.  Primary prevention of coronary heart disease in women through diet and lifestyle.

Authors:  M J Stampfer; F B Hu; J E Manson; E B Rimm; W C Willett
Journal:  N Engl J Med       Date:  2000-07-06       Impact factor: 91.245

9.  Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913.

Authors:  H Eriksson; K Caidahl; B Larsson; L O Ohlson; L Welin; L Wilhelmsen; K Svärdsudd
Journal:  Eur Heart J       Date:  1987-09       Impact factor: 29.983

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  55 in total

1.  The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing.

Authors:  Qiaoxiang Yin; Yusheng Zhao; Jiayue Li; Qiao Xue; Xingli Wu; Lei Gao; Ping He; Mei Zhu; Shiwen Wang
Journal:  Clin Cardiol       Date:  2011-05-31       Impact factor: 2.882

2.  Community prevalence of ideal cardiovascular health, by the American Heart Association definition, and relationship with cardiovascular disease incidence.

Authors:  Aaron R Folsom; Hiroshi Yatsuya; Jennifer A Nettleton; Pamela L Lutsey; Mary Cushman; Wayne D Rosamond
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

3.  American Heart Association's Life's Simple 7: Avoiding Heart Failure and Preserving Cardiac Structure and Function.

Authors:  Aaron R Folsom; Amil M Shah; Pamela L Lutsey; Nicholas S Roetker; Alvaro Alonso; Christy L Avery; Michael D Miedema; Suma Konety; Patricia P Chang; Scott D Solomon
Journal:  Am J Med       Date:  2015-04-20       Impact factor: 4.965

Review 4.  Nutritional Interventions in Heart Failure: Challenges and Opportunities.

Authors:  Conor P Kerley
Journal:  Curr Heart Fail Rep       Date:  2018-06

5.  High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction.

Authors:  Rebecca J Cogswell; Faye L Norby; Rebecca F Gottesman; Lin Y Chen; Scott Solomon; Amil Shah; Alvaro Alonso
Journal:  Eur J Heart Fail       Date:  2017-07-24       Impact factor: 15.534

6.  Contemporary Assessment of Left Ventricular Diastolic Function in Older Adults: The Atherosclerosis Risk in Communities Study.

Authors:  Amil M Shah; Brian Claggett; Dalane Kitzman; Tor Biering-Sørensen; Jan Skov Jensen; Susan Cheng; Kunihiro Matsushita; Suma Konety; Aaron R Folsom; Thomas H Mosley; Jacqueline D Wright; Gerardo Heiss; Scott D Solomon
Journal:  Circulation       Date:  2016-12-07       Impact factor: 29.690

7.  Ferritin levels and risk of heart failure-the Atherosclerosis Risk in Communities Study.

Authors:  Odilson M Silvestre; Alexandra Gonçalves; Wilson Nadruz; Brian Claggett; David Couper; John H Eckfeldt; James S Pankow; Stefan D Anker; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2016-12-14       Impact factor: 15.534

8.  Cardiac structure and function and leisure-time physical activity in the elderly: The Atherosclerosis Risk in Communities Study.

Authors:  Sheila M Hegde; Alexandra Gonçalves; Brian Claggett; Kelly R Evenson; Susan Cheng; Amil M Shah; Aaron R Folsom; Scott D Solomon
Journal:  Eur Heart J       Date:  2016-04-12       Impact factor: 29.983

9.  Smoking and Cardiac Structure and Function in the Elderly: The ARIC Study (Atherosclerosis Risk in Communities).

Authors:  Wilson Nadruz; Brian Claggett; Alexandra Gonçalves; Gabriela Querejeta-Roca; Miguel M Fernandes-Silva; Amil M Shah; Susan Cheng; Hirofumi Tanaka; Gerardo Heiss; Dalane W Kitzman; Scott D Solomon
Journal:  Circ Cardiovasc Imaging       Date:  2016-09       Impact factor: 7.792

10.  Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Authors:  Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon
Journal:  JACC Heart Fail       Date:  2013-04       Impact factor: 12.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.